BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 33193970)

  • 1. [Management of diabetes during Ramadan fasting: applications of international recommendations in clinical practice].
    Elamari S; Elaziz S; Chadli A; Farouqi A
    Pan Afr Med J; 2020; 36():316. PubMed ID: 33193970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.
    Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A
    J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitude, complications, ability of fasting and glycemic control in fasting Ramadan by children and adolescents with type 1 diabetes mellitus.
    Deeb A; Al Qahtani N; Akle M; Singh H; Assadi R; Attia S; Al Suwaidi H; Hussain T; Naglekerke N
    Diabetes Res Clin Pract; 2017 Apr; 126():10-15. PubMed ID: 28189949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
    Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
    Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitude and safety of patients with diabetes observing the Ramadan fast.
    Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z
    Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus.
    Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J
    Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
    Elhadd T; Bashir M; Baager KA; Ali HA; Almohannadi DHS; Dabbous Z; Malik RA; Abou-Samra AB;
    Diabetes Res Clin Pract; 2021 Feb; 172():108589. PubMed ID: 33316309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study.
    Hassoun AA; Al-Arouj M; Ibrahim M
    Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes control during Ramadan fasting.
    V RA; Zargar AH
    Cleve Clin J Med; 2017 May; 84(5):352-356. PubMed ID: 28530893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A; Zantout MS; Azar ST
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based risk factors for major complications during Ramadan fasting in people with diabetes grouped under IDF-DAR risk categories.
    Rahmatullah ; Ahmedani MY; Basit A; Zia S; Hasan I; Masroor Q; Shaikh A; Khan J; Iqbal W
    Diabetes Res Clin Pract; 2022 Mar; 185():109234. PubMed ID: 35124097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial.
    Zaghlol LY; Beirat AF; Amarin JZ; Hassoun Al Najar AM; Hasan YY; Qtaishat A; Tierney ME; Zaghlol RY; Zayed AA
    Front Endocrinol (Lausanne); 2021; 12():613826. PubMed ID: 34305809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes during Ramadan - PRE-approach model: presentation, risk stratification, education.
    Hassan A; Meo SA; Usmani AM; Shaikh TJ
    Eur Rev Med Pharmacol Sci; 2014; 18(12):1798-805. PubMed ID: 24992624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of Ramadan fasting on glucose variability in type 2 diabetes mellitus patients on oral anti diabetic agents.
    Harbuwono DS; Kurniawan F; Sudarsono NC; Tahapary DL
    PLoS One; 2020; 15(6):e0234443. PubMed ID: 32598395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.
    Salti I; Bénard E; Detournay B; Bianchi-Biscay M; Le Brigand C; Voinet C; Jabbar A;
    Diabetes Care; 2004 Oct; 27(10):2306-11. PubMed ID: 15451892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial.
    Al Sifri S; Basiounny A; Echtay A; Al Omari M; Harman-Boehm I; Kaddaha G; Al Tayeb K; Mahfouz AS; Al Elq A; Radican L; Ozesen C; Katzeff HL; Musser BJ; Suryawanshi S; Girman CJ; Davies MJ; Engel SS;
    Int J Clin Pract; 2011 Nov; 65(11):1132-40. PubMed ID: 21951832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan.
    Bashir M; Elhadd T; Ali H; Baagar K; Abdel Hakam IA; Al-Mohanadi DHS; Naem E; Al Abdulla A; Mohammed K; Abou-Samra AB
    Diabetes Metab Syndr; 2018 Nov; 12(6):965-968. PubMed ID: 29895446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of gender and patient background diversity on the changes in metabolic and biophysical profiles in people with type-2 diabetes from different ethnicities who fast during Ramadan (H1439); a prospective study from Qatar.
    Dabbous Z; Bashir M; Elzouki AN; Ahmed MS; Farouk S; Hassanien M; Malik RA; Abou Samra AB; Elhadd T;
    Diabetes Res Clin Pract; 2019 Jun; 152():171-176. PubMed ID: 30930290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.